Cargando…

Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects 10–15% of the global population and presents symptoms such as abdominal discomfort, bloating and altered bowel habits. IBS is believed to be influenced by gut microbiota alterations and low-grade inflammation. Bovine k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Yunyao, Park, Si Hong, Dallas, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574033/ https://www.ncbi.nlm.nih.gov/pubmed/37836457 http://dx.doi.org/10.3390/nu15194174

Ejemplares similares

The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome
por: Qu, Yunyao, et al.
Publicado: (2023)

Analysis of Bovine Kappa-Casein Glycomacropeptide by Liquid Chromatography–Tandem Mass Spectrometry
por: Qu, Yunyao, et al.
Publicado: (2021)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021)

Influence of Glycomacropeptide on Rehydration Characteristics of Micellar Casein Concentrate Powder
por: Panthi, Ram R., et al.
Publicado: (2021)

A Preclinical Study of Casein Glycomacropeptide as a Dietary Intervention for Acute Mania
por: Liebenberg, Nico, et al.
Publicado: (2018)

Cheese Whey Milk Adulteration Determination Using Casein Glycomacropeptide as an Indicator by HPLC
por: Vera-Bravo, Ricardo, et al.
Publicado: (2022)

Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis
por: Cui, Yongbo, et al.
Publicado: (2017)

Antibacterial and Remineralization Efficacy of Casein Phosphopeptide, Glycomacropeptide Nanocomplex, and Probiotics in Experimental Toothpastes: An In Vitro Comparative Study
por: Elgamily, Hanaa, et al.
Publicado: (2019)

The Use of Glycomacropeptide in Dietary Management of Phenylketonuria
por: Zaki, Osama K., et al.
Publicado: (2016)

Comparison of Solid-Phase Extraction Sorbents for Monitoring the In Vivo Intestinal Survival and Digestion of Kappa-Casein-Derived Caseinomacropeptide
por: Qu, Yunyao, et al.
Publicado: (2023)

The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model
por: Ahring, Kirsten K., et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Enrichment and Purification of Casein Glycomacropeptide from Whey Protein Isolate Using Supercritical Carbon Dioxide Processing and Membrane Ultrafiltration
por: Bonnaillie, Laetitia M., et al.
Publicado: (2014)

Glycomacropeptide in PKU—Does It Live Up to Its Potential?
por: Daly, Anne, et al.
Publicado: (2022)

Unveiling the Metabolic Effects of Glycomacropeptide
por: Pena, Maria João, et al.
Publicado: (2021)

Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations
por: Sauvé, Mathilde Foisy, et al.
Publicado: (2021)

The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management
por: Vulpoi, Radu Alexandru, et al.
Publicado: (2023)

Pathophysiology and Management of Irritable Bowel Syndrome
por: Kellow, John E
Publicado: (2001)

Clinical evaluation of Bilvadileha in the management of irritable bowel syndrome
por: Tiwari, Ramanand, et al.
Publicado: (2013)

Contemporary diagnosis and management of irritable bowel syndrome /
por: Drossman, Douglas A.
Publicado: (2002)

Are probiotics effective in management of irritable bowel syndrome?
por: Hosseini, Asieh, et al.
Publicado: (2012)

Irritable bowel syndrome and its psychological management
por: Tripathi, Ravikesh, et al.
Publicado: (2015)

Clinical Management of the Microbiome in Irritable Bowel Syndrome
por: Andrews, Christopher N, et al.
Publicado: (2020)

Update in diagnosis and management of irritable bowel syndrome
por: Hung, Tsung-Hsing, et al.
Publicado: (2023)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea
por: Ida, Motoko, et al.
Publicado: (2017)

Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study
por: Montanari, Chiara, et al.
Publicado: (2022)

Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Comorbid Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Jactel, Samuel N., et al.
Publicado: (2022)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
por: Bennet, Sean M.P., et al.
Publicado: (2015)

Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
por: Plavšić, Ivana, et al.
Publicado: (2015)

The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
por: Gu, Yu, et al.
Publicado: (2019)

Endotoxin-Binding Peptides Derived from Casein Glycomacropeptide Inhibit Lipopolysaccharide-Stimulated Inflammatory Responses via Blockade of NF-κB activation in macrophages
por: Cheng, Xue, et al.
Publicado: (2015)

Casein Glycomacropeptide Hydrolysates Exert Cytoprotective Effect against Cellular Oxidative Stress by Up-Regulating HO-1 Expression in HepG2 Cells
por: Li, Tiange, et al.
Publicado: (2017)

Effects of casein glycomacropeptide supplementation on growth performance, intestinal morphology, intestinal barrier permeability and inflammatory responses in Escherichia coli K88 challenged piglets
por: Rong, Yili, et al.
Publicado: (2015)

Optimal management of constipation associated with irritable bowel syndrome
por: Furnari, Manuele, et al.
Publicado: (2015)

The role of diet in the pathophysiology and management of irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome
por: Hong, Kyoung Sup, et al.
Publicado: (2009)

Irritable bowel syndrome in adults: Prevalence and risk factors
por: Zeeshan, Muhammad Hamayl, et al.
Publicado: (2022)

Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study
por: Stasi, Cristina, et al.
Publicado: (2017)

Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis
por: Park, Jae-Woo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ud2t93ll8136f7r0hq59pnprmr